Skip to content

Spinal Versus Epidural Analgesia in Laparotomic Liver Surgery

Spinal Analgesia Versus Epidural Analgesia in Minor Laparotomic Liver Surgery in an Enhanced Recovery Programme: A Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02647047
Enrollment
40
Registered
2016-01-06
Start date
2016-01-31
Completion date
2016-12-31
Last updated
2016-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Diseases, Liver Neoplasms, Secondary Malignant Neoplasm of Liver

Keywords

spinal analgesia, epidural analgesia, laparotomic liver resection, ERAS, length of stay

Brief summary

The purpose of this study is to evaluate the efficacy of spinal analgesia for minor laparotomic hepatectomy compared with epidural analgesia, monitoring visual analog scale (VAS). The investigators expect at least the same post-operative pain control in the two groups (non inferiority of pain control with spinal analgesia compared to epidural analgesia). Second endpoint is to verify whether after spinal analgesia there is a decrease in patient's length of hospitalization according to enhanced recovery after surgery (ERAS) principles.

Detailed description

Liver surgery is performed under general anesthesia. Loco-regional analgesia is generally performed before general anesthesia induction to obtain the best post-operative pain control,in association with intravenous analgesic drug administration. For minor laparotomic surgery (defined as the resection of up to three hepatic segments), if not contraindicated, in our hospital loco-regional analgesia is performed through the placement of a thoracic (T7-T8 or T8-T9) epidural catheter in which a local anesthetic (usually ropivacaine) and an opioid (usually sufentanil) are administered for the first three post-operative days. This is still considered the gold-standard for pain management in this surgery. In our institute, there is a dedicated acute pain service (APS) for pain management in the post-operative period. APS is also responsible for monitoring, registering and treating all side effects related to both the procedure and the drugs used. In laparoscopic abdominal surgery, instead of epidural analgesia, if not contraindicated, spinal analgesia with low dose morphine before general anesthesia induction is performed. This technique is actually considered efficacy and safe in these type of surgeries. The investigators therefore decided to test the efficacy of spinal analgesia versus epidural analgesia for minor liver surgery since anterior hepatic segments resection is less painful than major liver surgery because it requires less liver manipulation without significant involvement of the Glisson's capsule. This might imply a less incidence of procedure-related side effects such as post-dural puncture headache or site infections. Moreover, spinal analgesia may allow a earlier post-operative patients mobilization and thus a earlier hospital discharge. In this randomized controlled trial, the investigators therefore aim to randomize 40 consecutive patients into 2 arms. The experimental group will receive spinal analgesia (morphine 0.2 mg) for post-operative pain control while the control group will receive epidural analgesia (bolus of ropivacaine 0.2% 4-6 mL followed by continuous epidural infusion of ropivacaine 0.2%: 99 mL + sufentanil 50 mcg/mL: 1 mL). Randomization will be performed with closed opaque envelopes. During surgery, patients will be monitored as usual. Intraoperative blood losses and fluids administration will be recorded. Patients randomized into the epidural group will not receive local anesthetic administration through the epidural catheter during the hepatic resection phase to avoid hemodynamic instability. Once the hepatic resection phase is finished and euvolemic status is recovered, epidural analgesia will be administered as mentioned before. In patients in the spinal group, transversus abdominis plane (TAP) block with ropivacaine 0.375% 20 mL bilaterally or surgical wound infiltration with ropivacaine 0.75% 10- 20 mL will also be performed before anesthesia recovery. In both groups, post-operative pain control will be managed with intravenous acetaminophen 1000 mg 40 minutes before ending of surgery followed by intravenous administration of acetaminophen 1000 mg every 8 hours and a non-steroidal antinflammatory drug (ketorolac 30 mg) as a rescue therapy in the post-operative period if not contraindicated. Patients will be monitored every 24 hours until the achievement of the ready to discharge status defined as: * appropriate oral alimentation; * optimal pain control with drugs administered orally; * adequate ability in walking and personal care; * clinical, laboratory and instrumental absence of any post-operative complication; * intestinal function recovery; * patient consent to discharge.

Interventions

Administration of morphine 0.2 mg in subarachnoid space.

PROCEDUREEpidural analgesia

Bolus of ropivacaine 0.2% 4-6 mL followed by continuous epidural infusion of ropivacaine 0.2% 99 mL + sufentanil 50 mcg/mL 1 mL in epidural space

PROCEDURETransversus Abdominis Plane block

Administration of ropivacaine 0.375% 20 mL in the plane between the internal oblique and the transversus abdominis muscles, bilaterally

Infiltration of the surgical wound with ropivacaine 0.75% 10- 20 mL

DRUGAcetaminophen

Administration of 1000 mg of acetaminophen 40 minutes before ending of surgery followed by intravenous administration of 1000 mg every 8 hours

DRUGKetorolac

Administration of a non-steroidal antinflammatory drug (ketorolac 30 mg) as a rescue therapy

DRUGRopivacaine

Epidural bolus of ropivacaine 0.2% 4-6 mL followed by continuous epidural infusion of ropivacaine 0.2% 99 mL

DRUGSufentanil

Epidural continuous epidural infusion of sufentanil 50 mcg/mL 1 mL

Sponsors

Ospedale San Raffaele
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years old * Hospitalized patients * Surgical indication for minor laparotomic anterior liver resection (II, III, IV and V hepatic segment resection) * Surgical indication for laparotomic liver metastasectomy * Ability to provide an informed consent

Exclusion criteria

* Patient refusal to provide informed consent * Chronical therapy with opioids * Pregnancy or breastfeeding * Alcohol or drug abuse * Planned or unplanned post-operative intensive care unit admission * Contraindication to spinal/epidural analgesia * Severe liver or renal failure * Cognitive disorders, mental retard or psychiatric disorders * Allergy to any drug used

Design outcomes

Primary

MeasureTime frameDescription
Assessment of postoperative pain control by mean of the visual analog scale one day after surgery24 hours after surgeryVisual analog scale (VAS) will be assessed and compared between the two groups.
Assessment of postoperative pain control by mean of the visual analog scale early after surgeryWithin 1 hour after surgeryVisual analog scale (VAS) will be assessed and compared between the two groups.
Assessment of postoperative pain control by mean of the visual analog scale six hours after surgery6 hours after surgeryVisual analog scale (VAS) will be assessed and compared between the two groups.
Assessment of postoperative pain control by mean of the visual analog scale at hospital dischargeUp to 30 days after surgeryVisual analog scale (VAS) will be assessed and compared between the two groups.
Assessment of postoperative pain control by mean of the visual analog scale two days after surgery48 hours after surgeryVisual analog scale (VAS) will be assessed and compared between the two groups.
Assessment of postoperative pain control by mean of the visual analog scale three days after surgery72 hours after surgeryVisual analog scale (VAS) will be assessed and compared between the two groups.

Secondary

MeasureTime frameDescription
Ready to discharge statusUp to 30 days after surgeryThe postoperative day in which patients reach the ready to discharge status will be recorded and compared between the two groups.

Countries

Italy

Contacts

Primary ContactElena Bignami, M.D.
bignami.elena@hsr.it+39.02.2643.4524
Backup ContactRaffaella Reineke, M.D.
reineke.raffaella@hsr.it

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026